Palisade Bio (PALI) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.95% |
| Dec 31, 2025 | 104.26% |
| Sep 30, 2025 | -24.60% |
| Jun 30, 2025 | -5.12% |
| Mar 31, 2025 | -0.64% |
| Dec 31, 2024 | -4.55% |
| Sep 30, 2024 | -16.91% |
| Jun 30, 2024 | -4.87% |
| Mar 31, 2024 | 12.38% |
| Dec 31, 2023 | 66.96% |
| Sep 30, 2023 | 4.01% |
| Jun 30, 2023 | 2.26% |
| Mar 31, 2023 | 10.34% |
| Dec 31, 2022 | 33.78% |
| Sep 30, 2022 | 22.06% |
| Jun 30, 2022 | 30.38% |
| Mar 31, 2022 | 15.60% |
| Dec 31, 2021 | 17.64% |
| Sep 30, 2021 | 28.22% |
| Jun 30, 2021 | 17.42% |
| Mar 31, 2021 | -8.27% |
| Dec 31, 2020 | -39.87% |
| Sep 30, 2020 | -2.14% |
| Jun 30, 2020 | 8.83% |
| Mar 31, 2020 | -15.35% |
| Dec 31, 2019 | -33.71% |
| Sep 30, 2019 | 1.91% |
| Jun 30, 2019 | -35.78% |
| Mar 31, 2019 | -19.07% |
| Dec 31, 2018 | -19.89% |
| Sep 30, 2018 | -28.52% |
| Jun 30, 2018 | -29.52% |
| Mar 31, 2018 | -27.89% |
| Dec 31, 2017 | -22.51% |
| Sep 30, 2017 | -18.08% |
| Jun 30, 2017 | -25.91% |
| Mar 31, 2017 | -19.52% |
| Dec 31, 2016 | 5.20% |
| Sep 30, 2016 | -23.89% |
| Jun 30, 2016 | -1.23% |
| Mar 31, 2016 | -12.86% |
| Dec 31, 2015 | 19.55% |
| Sep 30, 2015 | 23.43% |
| Jun 30, 2015 | 88.19% |
| Mar 31, 2015 | 65.08% |
| Dec 31, 2014 | 94.02% |
| Sep 30, 2014 | 71.00% |
| Jun 30, 2014 | 63.83% |
| Dec 31, 2013 | 22.38% |